Congo Receives Vaccine Doses Amid Rapid Ebola Spread

Congo has received over 16,000 doses of the Ervebo vaccine as it confronts the swiftest Ebola outbreak on record, according to the nation’s health minister. These 16,250 doses arrived at N’djili International Airport in Kinshasa, late Friday. This shipment forms a portion of a total 70,000 doses promised by the World Health Organization and partners, announced Thursday. Further doses are expected next week.

The ongoing Ebola outbreak in Congo is linked to the rare Bundibugyo virus, which lacks an approved treatment or vaccine. This virus can spread rapidly and remain undetected since its symptoms resemble those of other ailments, including malaria. Although Ervebo is licensed for Ebola, it has shown past effectiveness in outbreaks. WHO indicates it might offer some protection against Bundibugyo.

The outbreak has led to 2,557 deaths from 5,375 confirmed cases across six provinces, spreading at an unmatched rate. It threatens to surpass the deadliest outbreak, which claimed over 11,000 lives in West Africa between 2014 and 2016. The Africa Centre for Disease Control states transmission has yet to peak and might escalate to triple its known rate.

Containment efforts face challenges due to armed conflicts involving government and rebel groups controlling critical cities in the hot spot area, as well as attacks on medical personnel and facilities. Additional obstacles include a mobile labor population, displaced individuals due to unrest, and insufficient basic infrastructure.